posted on 2016-08-22, 00:00authored byKarli
R. Reiding, Agnes L. Hipgrave Ederveen, Yoann Rombouts, Manfred Wuhrer
Glycosylation is
an abundant and important protein modification
with large influence on the properties and interactions of glycoconjugates.
Human plasma N-glycosylation has been the subject
of frequent investigation, revealing strong associations with physiological
and pathological conditions. Less well-characterized is the plasma N-glycosylation of the mouse, the most commonly used animal
model for studying human diseases, particularly with regard to differences
between strains and sexes. For this reason, we used MALDI-TOF(/TOF)-MS(/MS)
assisted by linkage-specific derivatization of the sialic acids to
comparatively analyze the plasma N-glycosylation
of both male and female mice originating from BALB/c, CD57BL/6, CD-1,
and Swiss Webster strains. The combined use of this analytical method
and the recently developed data processing software named MassyTools
allowed the relative quantification of the N-glycan
species within plasma, the distinction between α2,3- and α2,6-linked N-glycolylneuraminic acids (due to respective lactonization
and ethyl esterification), the detection of sialic acid O-acetylation, as well as the characterization of branching sialylation
(Neu5Gcα2,3-Hex-[Neu5Gcα2,6-]HexNAc). When analyzing the
glycosylation according to mouse sex, we found that female mice present
a considerably higher degree of core fucosylation (2–4-fold
depending on the strain), galactosylation, α2,6-linked sialylation,
and larger high-mannose type glycan species compared with their male
counterparts. Male mice, on the contrary, showed on average higher
α2,3-linked sialylation, branching sialylation, and putative
bisection. These differences together with sialic acid acetylation
proved to be strain-specific as well. Interestingly, the outbred strains
CD-1 and Swiss Webster displayed considerably larger interindividual
variation than inbred strains BALB/c and CD57BL/6, suggesting a strong
hereditable component of the observed plasma N-glycome.